#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arginase deficiency Brain stem glioma Sickle cell disease Ovarian cancer stage IV Uveitis Metabolic disorder Primary immunodeficiency syndrome Sickle cell anaemia Gastric cancer Immune thrombocytopenia Shprintzen-Goldberg syndrome Paroxysmal nocturnal haemoglobinuria Arteriosclerosis Renal disorder Astrocytoma More trials…

    Learn about Rare Diseases

    Atypical haemolytic uraemic syndrome – Trials in Disease Rosai-Dorfman syndrome – Life with Disease Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease Glycogen storage disease type V – Diagnostics Factor IX deficiency – Basic Information Medulloblastoma recurrent – Life with Disease Anaplastic thyroid cancer – Basic Information Synovial sarcoma metastatic – Basic Information Cystic fibrosis lung – Treatment Mantle cell lymphoma stage IV – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SGN-ALPV Rbd4059 ADX-038 Diclofenac Sodium Jab-21822 Vorinostat Elivaldogene Autotemcel Siponimod Nepafenac Cyclophosphamide VERTEPORFIN Vgl101 Islatravir RO7268489 Magnesium Sulfate Heptahydrate Xanomeline Tartrate FG001 Mycophenolate Sodium Tradipitant Ixazomib More therapies…

    Learn about Your Condition

    Nicotine dependence Head and neck cancer Demyelination Large cell lung cancer Premature baby Chronic hepatitis B Plasma cell myeloma refractory Metabolic syndrome Ventricular fibrillation Systemic sclerosis pulmonary Hepatotoxicity Hyperglycaemia Gingival bleeding Bacterial infection Hepatic adenoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on the Effects of Maplirpacept, Glofitamab, and Obinutuzumab in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma Not Eligible for Stem Cell Transplant

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Glofitamab
    • MAPLIRPACEPT
    • Obinutuzumab
    France Germany Spain

  • Study for Adults with Chronic Myeloid Leukemia Using Asciminib Alone or with Nilotinib

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Asciminib Hydrochloride
    • Nilotinib
    Italy Spain

  • Study on the Safety and Effectiveness of CSL889 for Adults and Adolescents with Sickle Cell Disease During Painful Crises

    Not recruiting

    4 1
    Investigated Diseases:
    • Sickle cell anaemia with crisis
    Investigated Drugs:
    • HEMOPEXIN, HUMAN
    Belgium France Germany Greece Italy The Netherlands +1

  • Study on the Effectiveness and Safety of Masitinib for Patients with Severe Systemic Mastocytosis Unresponsive to Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    • Mastocytosis
    Investigated Drugs:
    • Masitinib
    France Poland Spain

  • PET Imaging Study for Large B-Cell Lymphoma Patients Using 89Zr-CED88004S Before and After CAR T-Cell Therapy

    Not recruiting

    4 1 1
    Investigated Diseases:
    • B-cell lymphoma
    Investigated Drugs:
    • 89ZR-CED88004S
    The Netherlands

  • Study of Venetoclax and Decitabine for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia Eligible for Stem Cell Transplant

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Decitabine
    • Venetoclax
    Italy
Previous Page
1 … 46 47 48 49 50 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!